Hepa B vaccine dose

Reading File
Finding Sources
Searching the Web

Hepatitis B vaccine dose schedule adults children WHO 2025

Reading File
Reading File
Here is a full summary of Hepatitis B vaccine dosing:

Hepatitis B Vaccine - Dosing & Schedule

Standard Formulations & Doses

VaccineAge GroupDoseVolume# DosesSchedule
Engerix-B (GSK)0-19 years10 mcg0.5 mL30, 1-2, 6-18 months
Engerix-B (GSK)≥20 years20 mcg1.0 mL30, 1-2, 4-6 months
Recombivax HB (Merck)0-19 years5 mcg0.5 mL30, 1-2, 6-18 months
Recombivax HB (Merck)11-15 years10 mcg1.0 mL20, 4-6 months
Recombivax HB (Merck)≥20 years10 mcg1.0 mL30, 1-2, 4-6 months
Heplisav-B (Dynavax)≥18 years20 mcg0.5 mL20, 1 month (4 weeks apart)
Twinrix (HepA+HepB, GSK)≥18 years20 mcg1.0 mL30, 1, 6 months
Twinrix (accelerated)≥18 years20 mcg1.0 mL40, 7, 21-30 days, then 12 months
Note (CDC 2025): For infants born to HBsAg-negative mothers, birth-dose timing is now subject to shared clinical decision-making between parents and provider. For infants born to HBsAg-positive or unknown-status mothers, the birth dose (within 24 hours) + HBIG remains unchanged.

Route & Site

  • Intramuscular (IM) only - intradermal is NOT recommended (less reliable immune response)
  • Adults/older children: Deltoid muscle (preferred for reliable antibody conversion; gluteal injection risks fat deposition)
  • Infants/children <2 years: Anterolateral thigh

Special Populations

PopulationRegimen
Newborns (birth dose)Monovalent vaccine only, within 24 hours of birth
Premature (<2000 g)Delay first dose to 1 month of chronological age
Hemodialysis / immunocompromisedHigh-dose Recombivax HB (40 mcg/mL) x3 doses at 0, 1, 6 months; OR Engerix-B as four 2 mL injections at 0, 1, 2, 6 months
Post-exposure (unvaccinated)HBIG 0.06 mL/kg IM within 24 hours + begin vaccine series

India National Immunization Program

A 4-dose schedule is used:
  • Birth dose (within 24 hours) - monovalent
  • Then 3 doses at 6, 10, and 14 weeks as Pentavalent vaccine (DPT + HepB + Hib)

Minimum Dose Intervals

  • Dose 1 to Dose 2: 4 weeks
  • Dose 2 to Dose 3: 8 weeks
  • Dose 1 to Dose 3: 16 weeks
If a series is interrupted, it does NOT need to be restarted - simply resume from where it left off.

Efficacy & Duration

  • Induces protective anti-HBs (≥10 mIU/mL) in >95% of infants, children, and young adults
  • Protection drops below 90% after age 40, and to 65-75% by age 60
  • Duration: at least 15 years, and likely lifelong based on current evidence
Sources: Park's Textbook of Preventive and Social Medicine; Washington Manual of Medical Therapeutics; CDC Immunization Schedules 2025; Immunize.org HepB reference
This is a shared conversation. Sign in to Orris to start your own chat.